Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000906590 | SCV001051237 | likely benign | not provided | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001075368 | SCV001240989 | uncertain significance | Retinal dystrophy | 2018-06-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002542090 | SCV003675367 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.1187G>A (p.R396Q) alteration is located in exon 4 (coding exon 3) of the RP1 gene. This alteration results from a G to A substitution at nucleotide position 1187, causing the arginine (R) at amino acid position 396 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |